This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Humana (HUM) Brand to Open Senior-Centric Centers in Arizona
by Zacks Equity Research
Humana's (HUM) CenterWell brand announces plans to open nine centers by early 2023 to serve the aging population of the Phoenix region.
Acadia Healthcare (ACHC) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Acadia Healthcare (ACHC) Stock Up 3% on Q2 Earnings Beat
by Zacks Equity Research
Acadia Healthcare's (ACHC) second-quarter results benefit from a strong-performing U.S. business. A raised 2022 guidance with respect to EPS bodes well.
Are Medical Stocks Lagging Acadia Healthcare (ACHC) This Year?
by Zacks Equity Research
Here is how Acadia Healthcare (ACHC) and AxoGen (AXGN) have performed compared to their sector so far this year.
Acadia Healthcare (ACHC) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 9.09% and 0.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Philips' (PHG) Q2 Earnings Down on Supply Chain Constraints
by Zacks Equity Research
Koninklijke Philips' (PHG) Q2 top and bottom-line results reflect the negative impact of supply chain constraints and COVID lockdowns in China.
Here's Why Acadia Healthcare (ACHC) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Acadia Healthcare (ACHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Acadia Healthcare (ACHC) and Chinook Therapeutics (KDNY) have performed compared to their sector so far this year.
Centene (CNC) Divests Unit to Boost Focus on Core Business
by Zacks Equity Research
Centene (CNC) closes the deal to divest its pharmacy business. CNC primarily intends to pursue share repurchases with proceeds received from the transaction.
Factors that Make Acadia Healthcare (ACHC) an Attractive Bet Now
by Zacks Equity Research
Solid demand for behavioral healthcare services, growth-related efforts in the form of JVs, declining debt burden and sufficient cash-generating abilities continue to benefit Acadia Healthcare (ACHC).
Zacks Industry Outlook Highlights Acadia Healthcare, Pediatrix Medical, Tenet Healthcare and Discover Financial Services
by Zacks Equity Research
Acadia Healthcare, Pediatrix Medical, Tenet Healthcare and Discover Financial Services are part of Zacks Industry Outlook article.
2 Top Hospital Stocks to Buy Despite Industry Headwinds
by Kaibalya Pravo Dey
Rising supplies expense, wages and benefits, and other operating costs are lowering margins for the Zacks Medical-Hospital industry players. However, Acadia Healthcare and Pediatrix Medical are poised to win big with recovering patient volumes.
Ensign Group (ENSG) on a Buyout Binge to Boost US Footprint
by Zacks Equity Research
Ensign Group (ENSG) executes a slew of buyouts to offer better healthcare services to the U.S. residents and further penetrate its operational markets.
Teladoc (TDOC) Widens Primary360 Offerings With New Services
by Zacks Equity Research
Teladoc (TDOC) will provide in-home and on-demand phlebotomy services for its Primary360 members with Scarlet Health's support.
Why You Should Hold Elevance Health (ELV) in Your Portfolio
by Zacks Equity Research
Elevance Health (ELV) continues witnessing a rise in the usage of its virtual care services, which is a vital driver.
Why Pediatrix Medical (MD) is a Solid Bet for Your Portfolio
by Zacks Equity Research
Pediatrix Medical (MD) is expected to boost its services across maternal-fetal medicine, neonatology and obstetrics, plus 18 pediatric subspecialty offerings.
Is Acadia Healthcare (ACHC) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Acadia Healthcare (ACHC) and ClearPoint Neuro, Inc. (CLPT) have performed compared to their sector so far this year.
Acadia Healthcare (ACHC) JV to Build Behavioral Health Hospital
by Zacks Equity Research
Acadia Healthcare (ACHC) enters into a JV with Massachusetts-based Tufts Medicine to construct a behavioral health hospital and address the dire need for better behavioral healthcare services across Boston.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Is Acadia Healthcare (ACHC) Down 4.5% Since Last Earnings Report?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Acadia Healthcare (ACHC) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Acadia Healthcare (ACHC) Dips 1.6% Despite Q1 Earnings Beat
by Zacks Equity Research
Acadia Healthcare (ACHC) aims to add around 300 beds to its existing facilities in 2022.
What Awaits Meridian Bioscience (VIVO) This Earnings Season?
by Zacks Equity Research
Meridian Bioscience's (VIVO) fiscal second-quarter results are likely to reflect continued strength across both its segments.
Has Acadia Healthcare (ACHC) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Acadia Healthcare (ACHC) and Ono Pharmaceutical Co. (OPHLF) have performed compared to their sector so far this year.
Mednax (MD) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Mednax (MD) delivered earnings and revenue surprises of 22.22% and 1.75%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?